Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

1. Rossello, X.
2. Piñero, A.
3. Fernández-Jiménez, R.
4. Sánchez-González, J.
5. Pizarro, G.
6. Galán-Arriola, C.
7. Lobo-Gonzalez, M.
8. Vilchez, J.P.
9. García-Prieto, J.
10. García-Ruiz, J.M.
11. García-Álvarez, A.
12. Sanz-Rosa, D.
13. Ibanez, B.